Mikraki V, Ladanyi M, Chaganti R S
Laboratory of Cancer Genetics, Sloan-Kettering Institute, New York, New York.
Genes Chromosomes Cancer. 1991 Mar;3(2):117-21. doi: 10.1002/gcc.2870030206.
We report a new class of molecular lesions in the 5' region of the BCL2 protooncogene when it undergoes a t(14;18) translocation-associated rearrangement in the major break cluster (MBR) or minor break cluster (MCR) regions. Among 52 tumors assayed for BCL2 rearrangements using the MBR, MCR, and 5' probes, seven (six with MBR and one with MCR translocation breaks) showed aberrant bands in unique enzyme digests of DNA hybridized with the 5' probe. The aberrant bands in four tumors were in HindIII digests, in two they were in EcoRI digests, while the aberrant band in one was in a BamHI digest. The two EcoRI bands and two of the four HindIII bands were of identical sizes. Germline polymorphisms as the source of these bands was ruled out by appropriate control experiments. These results suggest that the bands were derived from point mutations or small deletions in the 5' region of BCL2. The significance of this alteration to BCL2 function in translocation-carrying tumors remains to be determined.
我们报告了一类新的分子病变,这类病变发生在BCL2原癌基因的5'区域,当它在主要断裂簇(MBR)或次要断裂簇(MCR)区域发生t(14;18)易位相关重排时。在使用MBR、MCR和5'探针检测BCL2重排的52个肿瘤中,7个(6个MBR易位断裂,1个MCR易位断裂)在与5'探针杂交的DNA的独特酶切中显示出异常条带。4个肿瘤中的异常条带出现在HindIII酶切中,2个出现在EcoRI酶切中,而1个中的异常条带出现在BamHI酶切中。2个EcoRI条带和4个HindIII条带中的2个大小相同。通过适当的对照实验排除了这些条带源自种系多态性的可能性。这些结果表明,这些条带源自BCL2 5'区域的点突变或小缺失。这种改变对携带易位肿瘤中BCL2功能的意义仍有待确定。